Font Size: a A A

The Study On Anti-tumour Effects Of Ginsenoside Rh2 And Rg3 From Panax Notoginseng On Inhibiting Proliferation And Anti-angiogenesis In Rat With B16 Transplanted Melanoma

Posted on:2009-04-05Degree:DoctorType:Dissertation
Country:ChinaCandidate:Y Q LiFull Text:PDF
GTID:1114360245957211Subject:Chinese medical science
Abstract/Summary:PDF Full Text Request
Objective:To study the anti-tumor effect of ginsenoside Rh2 and Rg3 from Panax notoginseng through in vivo experiment on the basis of rat model with transplanted B16melanoma,further more,to explore the possiable mechanism at the view of anti-angiogenesis.Methods:(1)Found rat modal with transplanted B16melanoma which were randomly divided into 9 groups,include the Rh2 or Rg3 with high dose group,the middle dose group and the low dose group,the Rh2 combined Rg3 group,the CTX group and the modle group.From the second day of inoculation,all rats were administrated respectively once a day for 10 days,except the CTX group injected intravenously once in another day for 3 times.In the process of experiment, observe the general conditions,weight and death.Until 15thday,mice were sacrificed to assay inhibitory rate of tumor and cound the thymus and spleen index,blood were obtained from vein of eyeball and centrifuged,the content of IL-2 and TNF-αin serum were detected with radioimmunoassay.(2)Found rat modal with transplanted B16melanoma which were randomly divided into 6 groups,include the modle group,the Rh2 group,the Rg3 group,and Rh2 combined with high dose Rg3,the middle dose Rg3 and the low dose Rg3 groups.All animals were administrated respectively once a day for 10 days,Until 15thday,they were sacrificed,and separate the tumor tissue fixed with 10%formalin,imbeded with paraffin.Observing the morphological changes of tumor tissue with light microscope after H-E staining.Detecting the vasculogenic mimicry by the mothed of double staining using CD31 and PAS,S-100 and PAS.Detecting the protein expression of VEGF,EphA2,Laminin,MMP-2 and VE-cadherin in neoplastic tissues with immuno-histochemical method.Results:(1)All mice entered the final analysis without loss.In the process of experiment,we found the general condition of rats in the modal group and CTX group get worse gradually.The rats in these two groups become poor appetite,emaciated,and the fur became lacking gloss,even depilate and sluggish,especially CTX group.But in each Rh2 and Rg3 groups,the general condition of animals is better than the modal and CTX groups.In additional,when seperating the tumor tissue,we found tumor of rats in the modal group present infiltrative growth,there are abundant tumor vesseles,and it is difficult to strip the amicula.Although in other groups, the tumor tissue have relatively complete amicula,less tumor vessel and is easy to strip, especially each Rh2 group and Rh2 combined Rg3 group.(2)Comparing with pretherapy,the rats in modal and CTX groups lose weight obviously, the organ index reduced,as well as the level of IL-2 and TNF-αin serum,especially CTX group.Administrated Rh2 and Rg3 alone or combinedly,both the rats'weight and the immune organs'weight increased in different extent,as well as the level of IL-2 and TNF-α,especially combined groups.There are significant different compared with control groups(P<0.05).(3)All different dosage of ginsenoside Rh2 and Rg3 could remarkably inhibit the growth of B16transplanted melanoma in rats,there are significant difference from average tumor weight of control groups(P<0.05),espacailly the high and middle dose of Rh2 group,the high dose of Rg3 group and the Rh2 combined Rg3 group,inhibition rate were 35.5%,30.1%,33.6%and 38.6%respectively.The inhibitation rate of the high and middle dose of Rg3 groups are lower than corresponding dose of Rh2 groups.(4)Compared the groups administrated Rh2 and Rg3 alone or combined with the modal group,both the vascular mimicry density and micro vascular density of tumor tissue are decreased,and the protein expression of CD31 and S-100 are down regulation,obviously each combined groups.(5)It shows that tumor tissue of the modal group expressed the proteins of VEGF,EphA2, MMP-2,VE-cadherin and Laminin,which are all strong positive.Each groups of Rh2 and Rg3 can markedly down-regulate the expression of those protein,especially the protein expression of VEGF,EphA2,VE-cadherin,MMP-2,which is more significant in each Rh2 and Rg3 combined groups,there are remarkble difference compared with the modal group(P<0.01 or P<0.05),and the protein expression of laminin also reduced,but there are not obvious difference between the modal group and each experimental groups.Conclusions:1.The active component Ginsenoside Rh2 and Rg3 from Panax notoginseng has a remarkable effect on inhibiting proliferation of B16transplanted melanoma with rat but no obvious side effects.They can improve the animal's whole condition.They don't reduce the weight and inhibit the immune function.It shows that Rh2 and Rg3 can improve the life quality of tumor-bearing mice at the same time of anti-tumor. 2.Ginsenoside Rh2 and Rg3 from Panax notoginseng can remarkablly inhibit the formation of angiogenesis and vasculogenic mimicry,thus obstruct the blood supply of tumor tissue effectually.3.The possible mechanism of effect of Ginsenoside Rh2 and Rg3 from Panax notoginseng on inhibiting vasculogenic mimicry in B16melanoma tissue is related to prevent the activation of EphA2 and down-regulate the expression of MMP-2 and VE-cadherin,thus inhibit the expression and the hydrolization of Laminin.The possible mechanism of their anti-angiogenesis effect is related to down-regulate the expression of VEGF and MMP-2.4.Inhibition of angiogenesis and vasculogenic mimicry probablly is one of the mechanismes of anti-tumor effect of Ginsenoside Rh2 and Rg3 from Panax notoginseng.5.It shows combination of Rh2 and Rg3 is more efficient on both inhibition of tumor blood supply and anti-tumor.
Keywords/Search Tags:Ginsenoside Rh2 and Rg3 from Panax notoginseng, B16 transplanted model, inhibitory rate of tumor, interleukin-2 (IL-2), tumor necros factor (TNF-α), VMD, MVD, VEGF, EphA2, MMP-2, VE-cadherin,Laminin
PDF Full Text Request
Related items